A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 24, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions

Depression

Interventions

DRUG

HR071603

HR071603 monotherapy ,nasal spray

DRUG

placebo

placebo,nasal spray

Trial Locations (1)

Beijing AnDing hospital affiliated to Capital Medical University, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04108234 - A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects | Biotech Hunter | Biotech Hunter